• Members Area (login)
  • Contact Us
  • Twitter
  • LinkedIn
Pharmabiotic Research Institute (PRI)
    • PRI
      • Home
      • Purpose & People
      • Representation
      • Partnerships
      • Task Groups
      • Members
      • Pharmabiotics Conference
      • Join PRI
    • Microbiome
      • Microbiome Science
      • Regulatory Status
      • Microbiome-based Medicinal Products
    • Regulatory Science
      • EU Landscape
      • Regulatory Framework
      • Regulatory Science & Tools
    • Insights
      • News & Events
      • PRI Publications
      • Member Job Openings
      • Members Area
Select Page
Ewha Womans University

Ewha Womans University

by Camille Bello | Sep 16, 2025 | Microbiome Research & Technology (public)

Sunwha Park M.D., Ph.D. Board-certified obstetrician-gynecologist and Clinical Assistant Professor Dr. Sunwha Park, MD, PhD, is an obstetrician-gynecologist and maternal-fetal medicine specialist at Ewha Womans University Medical Center, where she is Clinical...
BiomeBank

BiomeBank

by Camille Bello | Aug 28, 2025 | Microbiome Product Developer, Microbiome Research & Technology (public)

Jo Close Chief Operating Officer BiomeBank is building the future of microbial medicine, grounded in proven science and engineered for what the world needs next. The company has already delivered the first approved donor-derived microbiome drug for recurrent...
University of Zagreb, School of Medicine

University of Zagreb, School of Medicine

by Camille Bello | Jun 26, 2025 | Microbiome Research & Technology (public)

Mihaela Perić Senior Research Associate The Department for Intercellular Communication is part of the Center for Translational and Clinical Research, University of Zagreb School of Medicine. The Department was established within the academic community as a branch of...
FNRS UCLouvain – Metabolism & Nutrition (MNUT)

FNRS UCLouvain – Metabolism & Nutrition (MNUT)

by PRI | Aug 26, 2024 | Microbiome Research & Technology (public)

Amandine Everard Professor Academic research in microbiome at University (Univeristé Catholique de Louvain – UCL)...
Phycell (INSERM U1003) – University of Lille

Phycell (INSERM U1003) – University of Lille

by PRI | Jan 22, 2024 | Microbiome Research & Technology (public)

Mathias Chamalliard Research Director at INSERM - Deputy Director of the Laboratory of Cell Physiology The Chamaillard laboratory is interested in defining how mucosal immune response to the microbiota contribute to microbial tolerance, host defense and antitumoral...
Taiwan Microbiota Consortium

Taiwan Microbiota Consortium

by PRI | Jan 22, 2024 | Microbiome Research & Technology (public)

Chun-Ying Wu Chair The Taiwan Microbiota Consortium consists of a group of government-related management unit personnel, medical professionals, biotech and pharmaceutical industry representatives, and academic research experts, etc., who jointly form a cross-field,...
« Older Entries

Recent News & Events

  • Shaping the future of European biotechnology: PRI’s response to the EU Biotech Act Call for Evidence
  • PRI welcomes Camille Bello as Communication and Membership Manager
  • PRI Board of Director members elects Eleni Tsompanidou as New President
  • Microbiome-based Biomarkers – a multidisciplinary Delphi consensus (The Lancet Microbe)
  • 2024 Pharmabiotics Conference & Partnering – Lille

– Legal Notices –
© PRI 2022. All rights reserved. Copy prohibited unless explicitly authorized. Please contact the PRI.

Pharmabiotic Research Institute (PRI) | European Microbiome Regulatory Science Center
Non-Profit Association (loi 1901) – 1 bis, rue Sénateur Emile Roux, 11100 Narbonne, France

Agence de communication : Frelonbleu